Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

Parenteral dosage forms differ from all other pharmaceutical dosage forms


9th Annual Congress on Drug Design & Drug Formulation

October 19-20, 2017 Seoul, South Korea

Gulay Yelken Dem�±rel

Sanovel Pharmaceuticals, Turkey

Posters & Accepted Abstracts: Drug Des

Abstract :

Parenteral dosage forms differ from all other pharmaceutical dosage forms, because they are injected directly into body tissue through the primary protective systems of the human body; the skin and mucous membranes. They have many advantages like routes of administration, elimination of first pass effect and better absorption. They can be in a solution, suspension, emulsions, dry powders with freeze drying as well as microcapsules, nanoparticules or microemulsions. But there are some limitations for formulation development studies like drug stability, poor solubility, packaging, controlling the quality of these unique products, sterilization methods and evaluation of parenteral dosage forms issues. So,the main formulation development steps for new parenteral drug products And what about QbD development approach for parenteral dosage formsParenteral dosage forms represent excellent opportunities for life cycle management to the pharmaceutical companies. the future of parenteral dosage forms formulations. Sustained release drug delivery, such as depot formulations which are already available at the market, may be a good alternative.

Top